Brian J Mog

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Top Venues

Science translational medicine

Nature communications

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Brian J Mog, Nikita Marcou, Sarah R DiNapoli, Alexander H Pearlman, Tushar D Nichakawade, Michael S Hwang, Jacqueline Douglass, Emily Han-Chung Hsiue, Stephanie A Glavaris, Katharine M Wright, Maximilian Ferdinand Konig, Suman Paul, Nicolas Wyhs, Jiaxin Ge, Michelle S Miller, P Aitana Azurmendi, Evangeline Watson, Drew M Pardoll, Sandra B Gabelli, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities. Science translational medicine 16 (755) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Roger S Zou, Yang Liu, Oscar E Reyes Gaido, Maximilian F Konig, Brian J Mog, Leo L Shen, Franklin Aviles-Vazquez, Alberto Marin-Gonzalez, Taekjip Ha
Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq. Nature methods (2023)
Katharine M Wright, Sarah R DiNapoli, Michelle S Miller, P Aitana Azurmendi, Xiaowei Zhao, Zhiheng Yu, Mayukh Chakrabarti, WuXian Shi, Jacqueline Douglass, Michael S Hwang, Emily Han-Chung Hsiue, Brian J Mog, Alexander H Pearlman, Suman Paul, Maximilian Ferdinand Konig, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou, Sandra B Gabelli
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen. Nature communications 14 (1) (2023)
Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog, Michael S Hwang, Sarah R DiNapoli, Alexander H Pearlman, Michelle S Miller, Katharine M Wright, P Aitana Azurmendi, Qing Wang, Suman Paul, Annika Schaefer, Andrew D Skora, Marco Dal Molin, Maximilian Ferdinand Konig, Qiang Liu, Evangeline Watson, Yana Li, Michael B Murphy, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Sandra B Gabelli, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou
Bispecific antibodies targeting mutant RAS neoantigens. Science immunology 6 (57) (2022)
Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass, Michael S Hwang, Brian J Mog, Alexander H Pearlman, Suman Paul, Sarah R DiNapoli, Maximilian Ferdinand Konig, Qing Wang, Annika Schaefer, Michelle S Miller, Andrew D Skora, P Aitana Azurmendi, Michael B Murphy, Qiang Liu, Evangeline Watson, Yana Li, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Sandra B Gabelli, Shibin Zhou
Targeting a neoantigen derived from a common TP53 mutation. Science (New York, N.Y.) 371 (6533) (2021)
Michael S Hwang, Michelle S Miller, Puchong Thirawatananond, Jacqueline Douglass, Katharine M Wright, Emily Han-Chung Hsiue, Brian J Mog, Tihitina Y Aytenfisu, Michael B Murphy, P Aitana Azurmendi, Andrew D Skora, Alexander H Pearlman, Suman Paul, Sarah R DiNapoli, Maximilian Ferdinand Konig, Chetan Bettegowda, Drew M Pardoll, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou, Sandra B Gabelli
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens. Nature communications 12 (1) (2021)
Joshua David Cohen, Christopher Douville, Jonathan C Dudley, Brian J Mog, Maria Popoli, Janine Ptak, Lisa Dobbyn, Natalie Silliman, Joy Schaefer, Jeanne Tie, Peter Gibbs, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands. Nature biotechnology 39 (10) (2021)
Alexander H Pearlman, Michael S Hwang, Maximilian Ferdinand Konig, Emily Han-Chung Hsiue, Jacqueline Douglass, Sarah R DiNapoli, Brian J Mog, Chetan Bettegowda, Drew M Pardoll, Sandra B Gabelli, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou
Targeting public neoantigens for cancer immunotherapy. Nature cancer 2 (5) (2021)
Suman Paul, Alexander H Pearlman, Jacqueline Douglass, Brian J Mog, Emily Han-Chung Hsiue, Michael S Hwang, Sarah R DiNapoli, Maximilian Ferdinand Konig, Patrick A Brown, Katharine M Wright, Surojit Sur, Sandra B Gabelli, Yana Li, Gabriel Ghiaur, Drew M Pardoll, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Bert Vogelstein
TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Science translational medicine 13 (584) (2021)
Justina X Caushi, Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia, Boyang Zhang, Emily Han-Chung Hsiue, Brian J Mog, Wenpin Hou, Sune Justesen, Richard Blosser, Ada Tam, Valsamo Anagnostou, Tricia R Cottrell, Haidan Guo, Hok Yee Chan, Dipika Singh, Sampriti Thapa, Arbor G Dykema, Poromendro Burman, Begum Choudhury, Luis Aparicio, Laurene S Cheung, Mara Lanis, Zineb Belcaid, Margueritta El Asmar, Peter B Illei, Rulin Wang, Jennifer Meyers, Kornel Schuebel, Anuj Gupta, Alyza Skaist, Sarah J Wheelan, Jarushka Naidoo, Kristen A Marrone, Malcolm Brock, Jinny Ha, Errol L Bush, Bernard J Park, Matthew Bott, David R Jones, Joshua E Reuss, Victor E Velculescu, Jamie E Chaft, Kenneth W Kinzler, Shibin Zhou, Bert Vogelstein, Janis M Taube, Matthew D Hellmann, Julie R Brahmer, Taha Merghoub, Patrick M Forde, Srinivasan Yegnasubramanian, Hongkai Ji, Drew M Pardoll, Kellie N Smit
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596 (7870) (2021)